T1	Participants 84 117	patients with malignant neoplasm]
T2	Participants 207 239	patients with malignant neoplasm
T3	Participants 275 286	51 patients
T4	Participants 383 443	48 healthy adults were also studied as normal control group.
T5	Participants 997 1018	patients with cancer.
